Fennec Pharmaceuticals (FENC) Share-based Compensation Growth (5y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 160.56% |
| Sep 30, 2025 | 12.38% |
| Jun 30, 2025 | 134.65% |
| Mar 31, 2025 | 15.34% |
| Dec 31, 2024 | 50.67% |
| Sep 30, 2024 | 144.13% |
| Jun 30, 2024 | 22.82% |
| Mar 31, 2024 | 40.06% |
| Dec 31, 2023 | -11.54% |
| Sep 30, 2023 | 79.83% |
| Jun 30, 2023 | 98.27% |
| Mar 31, 2023 | 44.31% |
| Dec 31, 2022 | -50.05% |
| Sep 30, 2022 | -48.15% |
| Jun 30, 2022 | -34.30% |
| Mar 31, 2022 | -9.50% |
| Dec 31, 2021 | 127.12% |
| Sep 30, 2021 | 100.93% |
| Jun 30, 2021 | 139.01% |
| Dec 31, 2020 | -24.92% |
| Mar 31, 2020 | 112.61% |
| Dec 31, 2019 | -25.11% |
| Sep 30, 2019 | -29.66% |
| Mar 31, 2019 | 11.37% |
| Dec 31, 2018 | 116.17% |
| Sep 30, 2018 | 2.33% |
| Jun 30, 2018 | 23.41% |
| Dec 31, 2017 | 47.98% |
| Jun 30, 2017 | 75.87% |
| Sep 30, 2016 | -26.33% |
| Jun 30, 2016 | -19.08% |